# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA744105 | F | Inhibitory activity against NCI-H647 cell line using MTT assay(mutant p53) | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
2. | ALA971328 | F | Cytotoxicity against human NCI-H647 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
3. | ALA1646756 | F | Growth inhibition of human NCI-H647 cells assessed as ATP level after 96 hrs by CellTiter-Glo assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA3992017 | F | Cytotoxic activity in human NCI-H647 cells expressing Rad51 | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
5. | ALA3992018 | F | Potentiation of carboplatin induced DNA damage in human NCI-H647 cells expressing Rad51 assessed as carboplatin IC50 at 0.79 uM (Rvb IC50 = 172.53 uM) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
6. | ALA3992019 | F | Potentiation of carboplatin induced DNA damage in human NCI-H647 cells expressing Rad51 assessed as carboplatin IC50 at 2 uM (Rvb IC50 = 172.53 uM) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
7. | ALA5054352 | F | Anticancer activity against human NCI-H647 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA5230031 | F | Antiproliferative activity against human NCI-H647 cells assessed as reduction in cell viability at 50 uM incubated for 72 hrs by cellTiter-glo assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
9. | ALA5261773 | F | Cytotoxicity against human NCI-H647 cells measured after 8 days | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
10. | ALA5262606 | F | Cytotoxicity against human NCI-H647 cells measured after 3 days | Homo sapiens | 1 | cell-based format | Scientific Literature |